These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 2471453

  • 21. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M.
    Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245
    [Abstract] [Full Text] [Related]

  • 22. Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases.
    Nakao A, Suzuki Y, Isshiki K, Kimura Y, Takeda S, Kishimoto W, Nonami T, Harada A, Takagi H.
    Am J Gastroenterol; 1991 Jan 01; 86(1):62-6. PubMed ID: 1702578
    [Abstract] [Full Text] [Related]

  • 23. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M, Jung HH, Lee KH, Jeong SH.
    Am J Gastroenterol; 2006 Sep 01; 101(9):2051-9. PubMed ID: 16848813
    [Abstract] [Full Text] [Related]

  • 24. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Watanabe K, Magario N, Yokoo T, Naraki T.
    Cancer; 1999 Feb 15; 85(4):812-8. PubMed ID: 10091758
    [Abstract] [Full Text] [Related]

  • 25. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
    Tamura A, Oita T, Sakizono K, Nakajima T, Kasakura S.
    Rinsho Byori; 1998 Feb 15; 46(2):158-62. PubMed ID: 9528340
    [Abstract] [Full Text] [Related]

  • 26. [Studies on the mechanism of elevation of serum PIVKA-II levels in alcoholic liver cirrhosis].
    Sakizono K, Oita T, Eto M, Bito S, Takegawa H, Kasakura S.
    Rinsho Byori; 2002 Mar 15; 50(3):289-95. PubMed ID: 11985059
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
    Baek YH, Lee JH, Jang JS, Lee SW, Han JY, Jeong JS, Choi JC, Kim HY, Han SY.
    Hepatogastroenterology; 2009 Mar 15; 56(91-92):763-7. PubMed ID: 19621698
    [Abstract] [Full Text] [Related]

  • 28. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T, Beppu T, Horino K, Komori H, Hayashi H, Okabe H, Otao R, Horlad H, Ishiko T, Takamori H, Kikuchi K, Baba H.
    J Surg Oncol; 2010 Oct 01; 102(5):490-6. PubMed ID: 19937994
    [Abstract] [Full Text] [Related]

  • 29. [Tumor markers of hepatocellular carcinoma].
    Kubo S, Matsukawa M.
    Gan To Kagaku Ryoho; 2004 Dec 01; 31(13):2203-6. PubMed ID: 15628773
    [Abstract] [Full Text] [Related]

  • 30. [Development of highly sensitive assay for detection of low serum level of PIVKA-II and its clinical usefulness].
    Sakizono K, Oita T, Kuroda M, Kasakura S.
    Rinsho Byori; 1996 Sep 01; 44(9):871-6. PubMed ID: 8911073
    [Abstract] [Full Text] [Related]

  • 31. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M, Nakashima Y, Nakashima O, Kojiro M.
    Hepatology; 2001 Dec 01; 34(6):1128-34. PubMed ID: 11732002
    [Abstract] [Full Text] [Related]

  • 32. [The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein].
    Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Endo W, Mori T.
    Nihon Geka Gakkai Zasshi; 1990 May 01; 91(5):588-93. PubMed ID: 1696680
    [Abstract] [Full Text] [Related]

  • 33. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
    Kasahara A, Hayashi N, Fusamoto H, Kawada Y, Imai Y, Yamamoto H, Hayashi E, Ogihara T, Kamada T.
    Dig Dis Sci; 1993 Dec 01; 38(12):2170-6. PubMed ID: 7505217
    [Abstract] [Full Text] [Related]

  • 34. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
    Kishi K, Sonomura T, Mitsuzane K, Nishida N, Kimura M, Satoh M, Yamada R, Kodama N, Kinoshita M, Tanaka H.
    Radiat Med; 1992 Dec 01; 10(5):189-95. PubMed ID: 1279748
    [Abstract] [Full Text] [Related]

  • 35. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 01; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 36. Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma.
    Ajisaka H, Shimizu K, Miwa K.
    J Surg Oncol; 2003 Oct 01; 84(2):89-93. PubMed ID: 14502782
    [Abstract] [Full Text] [Related]

  • 37. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.
    Am J Gastroenterol; 2006 Sep 01; 101(9):2038-43. PubMed ID: 16848811
    [Abstract] [Full Text] [Related]

  • 38. [Clinical evaluation of PIVKA-II in patients with hepatocellular carcinoma. Detection of PIVKA-II by EIA using anti-PIVKA-II monoclonal antibody].
    Ohtani M, Ido K, Kawamoto C, Kimura K.
    Rinsho Byori; 1989 Apr 01; 37(4):405-9. PubMed ID: 2545953
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
    Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K.
    Am J Gastroenterol; 1996 Jul 01; 91(7):1380-3. PubMed ID: 8677999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.